Get started

Healthcare

CVS, waiting for the breakoutThe stock is moving in a sideways parallel channel started at the beginning of 2017. This movement can be a redistribution or an accumulation phase, it depends if it breaks lower or higher. If the price breaks lower the minimum target is around 70 and if it breaks higher the minimum target is around 88. The breakout must be confirmed by very high volume to avoid fakeouts or pullbacks. The informations and the strategies discussed are NOT recommendation to buy, sell or trade any securities. They are strictly for educational and illustrative purposes.
NYSE:CVS
by UnknownUnicorn1249598
PTOY LONG HODL Get it while it's hot!This company is going places, I have been researching the team, the fundamentals, and TA for about a week or two for a few hours every day. The entirety of the staff checks out and they have built a HIPPA approved platform to interface with EMR companies. This will revolutionize healthcare as we know it, they have a free app coming out this month for patients to interface with their care team as well as other individuals with similar conditions. They have been chosen to present at a convention in Atlanta October 2017, have been picked multiple times in multiple places one of the top ten most influential companies, not even at events solely restricted to the crypto space...top ten out of hundreds of other companies. This will disrupt healthcare IT as we know it! They are also doing a trial at 8 hospitals for ninety days. This will climb throughout that time and if even one of those 8 hospitals signs on after the 90 day trial that will send it flying. I have connections in the healthcare space, (specifically pharmaceuticals and EMR) and I have showed them this company and their plan of action and they agree that it is a winner. Oh did I mention they are HIPPA compliant, yes I did, but that is HUGE. My understanding is that they can interface with current EMR companies as well as having the technology to possibly replace them down the road. My understanding is they are also aligned with Kaiser Permanente which is almost enough right there. If you have a little more time than I have taken already there is a great analysis on medium that I cannot take credit for. medium.com Writing this I feel like a schill but this is far from the truth, I have bought in 3x and plan to as much more as I can, my family is and my friends are. This one is a win that I may not ever let go of.
Long
by Uptrender2ThePhlow
3
A Low Beta Way to Play Biopharma IndustryAttached is a piece about SWKH in which I discuss the value within the company, and I suggest it as a way of exposure to the healthcare technology sector without the risk. How is that possible? SWKH uses debt investments when making acquisitions in companies. Debt investments are usually the first investments to be paid back in full when a company undergoes liquidation / bankruptcy. Give it a read and let me know what y'all think. rockvuecapital.wordpress.com All the best, RC
SLong
by BrandonBeylo
Biotech (IBB) - trade of the yearIBB is at multi-year cross roads. Ideal for straddles / strangles. A dropping RSI points to a weekly downtrend. Both trade ideas are plotted. From a fundamental perspective, I believe @realdonaldtrump is right, biotech is getting away with murder. I get one of my meds from overseas because it's 1/182 the cost. Yes, you read it right. It costs me $1 there and $182 here for 10 pills. North America has one of the most affordable: 1. housing, 2. food, 3. cars, 4. Gas, 5. tech, 6. Financial Markets anywhere in the world. But what is charged for healthcare is OUTRAGEOUS. An open heart surgery done in India, China, Malaysia, Singapore, Russia costs $50,000 including business class airfare and 5 star accommodations ($20,000 is surgery cost) . In USA it is $250,000. This is a topic that Dems and Republicans are aligned on, it's very important for the most powerful country in the world to have affordable health care and thereby provide capability for it's citizens to live a happy meaningful life. Reducing healthcare costs should also increase profits for S&P by about 10% within the next 3 years as it's one of the major expense for any company.
NASDAQ:IBBShort
by iamajeya
Long term potential (1-3 months)Haven't posted on here in a bit but wanted to share my thoughts and most recent investment in $RNVA. I bought into RNVA on Tuesday at 0.083 per share for a little over 12k shares. I heard about the company through the penny stock subreddit and did some DD and decided to make an investment into it. My thoughts are as follows- Contrary to what Stocktwits believed yesterday, this is not a stock to get rich quick from. Many people have the pipe dream of this stock becoming the next $DRYS or $ETRM. Most likely not gonna happen but I would not complain if it did. The company is facing an impending reverse split if it cannot maintain $1+ a share by March for 10 days. The first thing I'm watching for is for us to reach $1 a share. If we can do that within the next few months and stay above it for 10 days the reverse split will be pushed back or not necessarily entirely. RNVA appears to have the motivation to see it reach $1 a share and to avoid an R/S, however at the end of the day it may not come near $1. In the event that it doesn't and a R/S occurs the stock soars to the company price target of $18.5 a share. Just some thoughts In it for the long haul
RLong
by Cryptocol